DALLAS - Baylor Scott & White is reporting some good news about treatment for COVID-19 patients.The hospital released some results of a study on the use of Remdesivir.Baylor Scott & White Health is one of 180 hospitals participating in a worldwide Gilead Sciences study of its antiviral drug Remdesivir to treat people who are severely hospitalized with COVID-19.MORE: Coronavirus coverage“What’s a patient come to a hospital for?
They want to live longer, they want to live better, and they want to get better,” said Dr. Robert Gottlieb, who is a cardiologist at Baylor Scott & White.AdvertisementAnd hospital officials said the results show Remdesivir is doing just that, consistently shortening recovery time and saving lives.“And now we have.